Quisinostat dihydrochloride (Synonyms: JNJ-26481585 dihydrochloride) |
| Catalog No.GC19936 |
Le dichlorhydrate de quisinostat (dichlorhydrate JNJ-26481585) est un puissant inhibiteur pan-HDAC disponible par voie orale avec des CI50 de 0,11 nM, 0,33 nM, 0,64 nM, 0,46 nM et 0,37 nM pour HDAC1, HDAC2, HDAC4, HDAC10 et HDAC11, respectivement. Le dichlorhydrate de quisinostat a une activité antitumorale À large spectre.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 875320-31-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity[1].
Average Rating: 5 (Based on Reviews and 19 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *